This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Racemethionine
- DrugBank Accession Number
- DB13972
- Background
A preparation of methionine that includes a mixture of D-methionine and L-methionine isomers.
- Type
- Small Molecule
- Groups
- Approved, Experimental
- Structure
Structure for Racemethionine (DB13972)
- Weight
- Average: 149.211
Monoisotopic: 149.051049291 - Chemical Formula
- C5H11NO2S
- Synonyms
- (+-)-Methionine
- DL-Methionine
- DL-Methioninum
- metionina
- Racemethionine
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image 24 Multivitamins + Minerals Racemethionine (25 mg) + Ascorbic acid (150 mg) + Beta carotene (10000 unit) + Biotin (25 mcg) + Calcium (130 mg) + Cholecalciferol (400 unit) + Choline bitartrate (25 mg) + Chromium (20 mcg) + Copper (1 mg) + Cyanocobalamin (25 mcg) + Ferrous fumarate (15 mg) + Folic acid (.8 mg) + Inositol (25 mg) + Magnesium (65 mg) + Manganese (2 mg) + Molybdenum (20 mcg) + Niacin (25 mg) + Calcium pantothenate (25 mg) + Potassium (15 mg) + Potassium Iodide (.1 mg) + Pyridoxine hydrochloride (25 mg) + Riboflavin (25 mg) + Selenium (20 mcg) + Thiamine hydrochloride (25 mg) + Vanadium (20 mcg) + Vitamin A palmitate (5000 unit) + Vitamin E (50 unit) + Zinc (10 mg) Tablet Oral Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. 1997-04-30 2002-07-31 Canada 
50 Plus Racemethionine (20 mg) + Ascorbic acid (200 mg) + Biotin (20 mcg) + Choline bitartrate (20 mg) + Cyanocobalamin (20 mcg) + Folic acid (.2 mg) + Inositol (20 mg) + Niacin (20 mg) + Calcium pantothenate (20 mg) + Pyridoxine hydrochloride (20 mg) + Riboflavin (20 mg) + Thiamine hydrochloride (20 mg) + Vitamin A palmitate (10000 unit) + Vitamin D (400 unit) + Vitamin E (20 unit) Tablet Oral Quest Vitamins A Div Of Purity Life Health Products 1998-08-04 2001-07-06 Canada 8.5% Freamine III Racemethionine (450 mg / 100 mL) + Alanine (600 mg / 100 mL) + Arginine (810 mg / 100 mL) + Cysteine hydrochloride (13.9 mg / 100 mL) + Glycine (1.19 g / 100 mL) + Histidine (240 mg / 100 mL) + Isoleucine (590 mg / 100 mL) + Leucine (770 mg / 100 mL) + Lysine acetate (620 mg / 100 mL) + Phenylalanine (480 mg / 100 mL) + Proline (950 mg / 100 mL) + Serine (500 mg / 100 mL) + Threonine (340 mg / 100 mL) + Tryptophan (130 mg / 100 mL) + Valine (560 mg / 100 mL) Liquid Intravenous B. Braun Medical Inc. 1999-05-17 2012-04-16 Canada A/o-26 - Caplet Racemethionine (50 mg) + Beta carotene (7500 unit) + Calcium (75 mg) + Calcium ascorbate (250 mg) + Copper (1 mg) + DL-alpha tocopheryl acetate (100 unit) + Folic acid (.4 mg) + Manganese (2.5 mg) + Selenium (100 mcg) + Zinc (7.5 mg) Tablet Oral Enviro Tech International Canada 1996-12-19 1999-07-26 Canada Amino-cerv Racemethionine (0.83 %) + Cystine (0.354 %) + Inositol (0.83 %) + Sodium propionate (0.50 %) + Urea (8.34 %) Cream Vaginal Milex, A Coopersurgical Co. 1952-12-31 2007-07-26 Canada AMINOPLASMAL® 10% E Racemethionine (4.4 g) + Alanine (10.5 g) + Arginine (11.5 g) + Aspartic acid (5.6 g) + Glutamic acid (7.2 g) + Glycine (12 g) + Histidine (3 g) + Isoleucine (5 g) + Leucine (8.9 g) + Lysine hydrochloride (8.56 g) + Magnesium chloride hexahydrate (0.508 g) + Phenylalanine (4.7 g) + Potassium acetate (2.453 g) + Proline (5.5 g) + Serine (2.3 g) + Sodium acetate trihydrate (2.858 g) + Sodium hydroxide (0.36 g) + Sodium phosphate, dibasic dodecahydrate (3.581 g) + Threonine (4.2 g) + Tryptophan (1.6 g) + Tyrosine (0.4 g) + Valine (6.2 g) Solution Intravenous B. BRAUN MEDICAL S.A. 2015-07-27 Not applicable Colombia 
AMINOVEN® 15 % Racemethionine (0.38 g) + Alanine (2.5 g) + Arginine (2 g) + Glycine (1.85 g) + Histidine (0.73 g) + Isoleucine (0.52 g) + Leucine (0.89 g) + Lysine acetate (1.566 g) + Phenylalanine (0.55 g) + Proline (1.7 g) + Serine (0.96 g) + Taurine (0.2 g) + Threonine (0.86 g) + Tryptophan (0.16 g) + Tyrosine (0.04 g) + Valine (0.55 g) Solution Intravenous Fresenius Kabi Austria GmbH 2006-11-10 Not applicable Colombia Body Tropics Plus Tab Racemethionine (100 mg) + Bromelains (50 mg) + Choline bitartrate (500 mg) + Inositol (250 mg) + Pyridoxine (25 mg) Tablet Oral Pro Shop Inc. 1994-12-31 2008-08-02 Canada C. Vit-min Formula Racemethionine (3 mg) + Ascorbic acid (100 mg) + Biotin (30 mcg) + Calcium (175 mg) + Cholecalciferol (400 unit) + Choline (30 mg) + Chromium (50 mcg) + Copper (5 mg) + Cyanocobalamin (100 mcg) + Ferrous fumarate (10 mg) + Folic acid (0.600 mg) + Inositol (30 mg) + Magnesium (80 mg) + Manganese (5 mg) + Molybdenum (25 mcg) + Nicotinamide (50 mg) + Calcium pantothenate (50 mg) + Potassium (40 mg) + Potassium Iodide (0.15 mg) + Pyridoxine hydrochloride (50 mg) + Riboflavin (50 mg) + Sodium selenite (200 mcg) + Silicon (0.01 mg) + Thiamine (50 mg) + Vanadium (10 mcg) + Vitamin A (5000 unit) + Zinc (40 mg) + alpha-Tocopherol acetate (100 unit) Tablet Oral Nutramed Laboratories Inc. Not applicable Not applicable Canada Card-floe II Tab Racemethionine (16 mg) + Ascorbic acid (400 mg) + Beta carotene (1000 unit) + Biotin (5 mcg) + Calcium (42 mg) + Choline (66 mg) + Chromium (13 mcg) + Cyanocobalamin (16 mcg) + Folic acid (.06 mg) + Inositol (4 mg) + Magnesium (42 mg) + Manganese (.8 mg) + Niacin (7 mg) + Nicotinamide (2 mg) + Calcium pantothenate (33 mg) + Potassium (42 mg) + Potassium Iodide (.03 mg) + Pyridoxine hydrochloride (15 mg) + Riboflavin (3 mg) + Selenium (20 mcg) + Thiamine hydrochloride (18 mg) + Vitamin A palmitate (2000 unit) + Vitamin E (60 unit) + Zinc (2.5 mg) Tablet Oral Sisu Inc. 1994-12-31 2009-08-04 Canada
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 73JWT2K6T3
- CAS number
- 59-51-8
- InChI Key
- FFEARJCKVFRZRR-UHFFFAOYSA-N
- InChI
- InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)
- IUPAC Name
- 2-amino-4-(methylsulfanyl)butanoic acid
- SMILES
- CSCCC(N)C(O)=O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0033951
- KEGG Drug
- D04983
- KEGG Compound
- C01733
- ChemSpider
- 853
- BindingDB
- 86195
- 9100
- ChEBI
- 16811
- ChEMBL
- CHEMBL274119
- Wikipedia
- Methionine
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Intravenous Cream Vaginal Solution Intravenous Solution, concentrate Intravenous Solution, concentrate Intravenous 5 g Capsule Oral Tablet Oral Liquid Oral Tablet, extended release Oral Emulsion Parenteral Emulsion Intravenous Emulsion Intravenous 4 g Solution Parenteral Tablet, sugar coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 23.9 mg/mL ALOGPS logP -1.8 ALOGPS logP -2.2 ChemAxon logS -0.8 ALOGPS pKa (Strongest Acidic) 2.53 ChemAxon pKa (Strongest Basic) 9.5 ChemAxon Physiological Charge 0 ChemAxon Hydrogen Acceptor Count 3 ChemAxon Hydrogen Donor Count 2 ChemAxon Polar Surface Area 63.32 Å2 ChemAxon Rotatable Bond Count 4 ChemAxon Refractivity 37.59 m3·mol-1 ChemAxon Polarizability 15.61 Å3 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter No ChemAxon Veber's Rule No ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Drug created at January 17, 2018 22:23 / Updated at October 20, 2021 17:29